Djomangan Adama Ouattara
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Djomangan Adama Ouattara has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
Wassim Abou-Jaoudé
3 shared publications- Céline Brochot
Institut National de l'Environnement Industriel et des Risques (INERIS), Unité Modèles pour l'Ecotoxicologie et la Toxicologie (METO), Parc ALATA BP2, 60550 Verneuil en Halatte, France
2 shared publications Damien Ernst
University of Liège , Department of Electrical Engineering and Computer Science, Montefiore Institute, Liège, Belgium
2 shared publications- Guy-Bart Stan
Department of Bioengineering, Imperial College London, London, U.K.
2 shared publications Marcelle Kaufman
Univ Libre Bruxelles, Fac Sci, Unit Theoret & Computat Biol, B-1050 Brussels, Belgium
2 shared publications- Pablo S. Rivadeneira
Grupo GITA, Facultad de Minas, Universidad Nacional de Colombia, Medellín, Colombia
2 shared publications
Latest Publications
- Open Access
- 1 October 2014
- Published by SAGE Publications in BioResearch Open Access
- Vol. 3 (5) , 233-241
Mathematical Modeling of HIV Dynamics After Antiretroviral Therapy Initiation: A Review
This review shows the potential ground-breaking impact that mathematical tools may have in the analysis and the understanding of the HIV dynamics. In the first part, early diagnosis of immunological failure is inferred from the estimation of certain parameters of a mathematical model of the HIV infection dynamics. This method is supported by clinical research results from an original clinical trial: data just after 1 month following therapy initiation are used to carry out the model identification. The diagnosis is shown to be consistent with results from monitoring of the patients after 6 months. In the second part of this review, prospective research results are given for the design of individual anti-HIV treatments optimizing the recovery of the immune system and minimizing side effects. In this respect, two methods are discussed. The first one combines HIV population dynamics with pharmacokinetics and pharmacodynamics models to generate drug treatments using impulsive control systems. The second one is based on optimal control theory and uses a recently published differential equation to model the side effects produced by highly active antiretroviral therapy therapies. The main advantage of these revisited methods is that the drug treatment is computed directly in amounts of drugs, which is easier to interpret by physicians and patients.
- 1 October 2014
- Published by SAGE Publications in BioResearch Open Access
- Vol. 3 (5) , 233-241
Open AccessMathematical Modeling of HIV Dynamics After Antiretroviral Therapy Initiation: A Review
This review shows the potential ground-breaking impact that mathematical tools may have in the analysis and the understanding of the HIV dynamics. In the first part, early diagnosis of immunological failure is inferred from the estimation of certain parameters of a mathematical model of the HIV infection dynamics. This method is supported by clinical research results from an original clinical trial: data just after 1 month following therapy initiation are used to carry out the model identification. The diagnosis is shown to be consistent with results from monitoring of the patients after 6 months. In the second part of this review, prospective research results are given for the design of individual anti-HIV treatments optimizing the recovery of the immune system and minimizing side effects. In this respect, two methods are discussed. The first one combines HIV population dynamics with pharmacokinetics and pharmacodynamics models to generate drug treatments using impulsive control systems. The second one is based on optimal control theory and uses a recently published differential equation to model the side effects produced by highly active antiretroviral therapy therapies. The main advantage of these revisited methods is that the drug treatment is computed directly in amounts of drugs, which is easier to interpret by physicians and patients.
- Open Access
- 1 September 2014
- Published by SAGE Publications in AIDS Research and Human Retroviruses
- Vol. 30 (9) , 831-834
Mathematical Modeling of HIV Dynamics After Antiretroviral Therapy Initiation: A Clinical Research Study
International audienceImmunological failure is identified from the estimation of certain parameters of a mathematical model of the HIV infection dynamics. This identification is supported by clinical research results from an original clinical trial. Standard clinical data were collected from infected patients starting Highly Active Anti-Retroviral Therapy (HAART), just after one month following therapy initiation and were used to carry out the model identification. The early diagnosis is shown to be consistent with the patients monitoring after six months
- 1 September 2014
- Published by SAGE Publications in AIDS Research and Human Retroviruses
- Vol. 30 (9) , 831-834
Open AccessMathematical Modeling of HIV Dynamics After Antiretroviral Therapy Initiation: A Clinical Research Study
International audienceImmunological failure is identified from the estimation of certain parameters of a mathematical model of the HIV infection dynamics. This identification is supported by clinical research results from an original clinical trial. Standard clinical data were collected from infected patients starting Highly Active Anti-Retroviral Therapy (HAART), just after one month following therapy initiation and were used to carry out the model identification. The early diagnosis is shown to be consistent with the patients monitoring after six months
- 1 January 2013
- Published by Elsevier in Journal of Theoretical Biology
- Vol. 317, 407-417
Excitability in the host–pathogen interactions of HIV infection and emergence of viral load blips
- 1 January 2013
- Published by Elsevier in Journal of Theoretical Biology
- Vol. 317, 407-417
Excitability in the host–pathogen interactions of HIV infection and emergence of viral load blips
- 18 April 2012
- Published by Oxford University Press (OUP) in Molecular BioSystems
- Vol. 8 (7) , 1908-1920
Metabolomics-on-a-chip and metabolic flux analysis for label-free modeling of the internal metabolism of HepG2/C3A cells
In vitro microfluidic systems are increasingly used as an alternative to standard Petri dishes in bioengineering and metabolomic investigations, as they are expected to provide cellular environments close to the in vivo conditions. In this work, we combined the recently developed “metabolomics-on-a-chip” approach with metabolic flux analysis to model the metabolic network of the hepatoma HepG2/C3A cell line and to infer the distribution of intracellular metabolic fluxes in standard Petri dishes and microfluidic biochips. A high pyruvate reduction to lactate was observed in both systems, suggesting that the cells operate in oxygen-limited environments. Our results also indicate that HepG2/C3A cells in the biochip are characterized by a higher consumption rate of oxygen, presumably due to a higher oxygenation rate in the microfluidic environment. This leads to a higher entry of the ultimate glycolytic product, acetyl-CoA, into the Krebs cycle. These findings are supported by the transcriptional activity of HepG2/C3A cells in both systems since we observed that genes regulated by a HIF-1 (hypoxia-regulated factor-1) transcriptional factor were over expressed under the Petri conditions, but to a lesser extent in the biochip.
- 18 April 2012
- Published by Oxford University Press (OUP) in Molecular BioSystems
- Vol. 8 (7) , 1908-1920
Metabolomics-on-a-chip and metabolic flux analysis for label-free modeling of the internal metabolism of HepG2/C3A cells
In vitro microfluidic systems are increasingly used as an alternative to standard Petri dishes in bioengineering and metabolomic investigations, as they are expected to provide cellular environments close to the in vivo conditions. In this work, we combined the recently developed “metabolomics-on-a-chip” approach with metabolic flux analysis to model the metabolic network of the hepatoma HepG2/C3A cell line and to infer the distribution of intracellular metabolic fluxes in standard Petri dishes and microfluidic biochips. A high pyruvate reduction to lactate was observed in both systems, suggesting that the cells operate in oxygen-limited environments. Our results also indicate that HepG2/C3A cells in the biochip are characterized by a higher consumption rate of oxygen, presumably due to a higher oxygenation rate in the microfluidic environment. This leads to a higher entry of the ultimate glycolytic product, acetyl-CoA, into the Krebs cycle. These findings are supported by the transcriptional activity of HepG2/C3A cells in both systems since we observed that genes regulated by a HIF-1 (hypoxia-regulated factor-1) transcriptional factor were over expressed under the Petri conditions, but to a lesser extent in the biochip.
- 1 September 2011
- Published by Elsevier in Toxicology Letters
- Vol. 205 (3) , 310-319
Kinetic modelling of in vitro cell-based assays to characterize non-specific bindings and ADME processes in a static and a perfused fluidic system
- 1 September 2011
- Published by Elsevier in Toxicology Letters
- Vol. 205 (3) , 310-319
Kinetic modelling of in vitro cell-based assays to characterize non-specific bindings and ADME processes in a static and a perfused fluidic system
- 21 June 2010
- Published by Elsevier in Journal of Theoretical Biology
- Vol. 264 (4) , 1177-1189
From structure to dynamics: Frequency tuning in the p53-Mdm2 network. II: Differential and stochastic approaches
- 21 June 2010
- Published by Elsevier in Journal of Theoretical Biology
- Vol. 264 (4) , 1177-1189
From structure to dynamics: Frequency tuning in the p53-Mdm2 network. II: Differential and stochastic approaches
- 1 June 2009
- Published by Elsevier in Journal of Theoretical Biology
- Vol. 258 (4) , 561-577
From structure to dynamics: Frequency tuning in the p53–Mdm2 network
- 1 June 2009
- Published by Elsevier in Journal of Theoretical Biology
- Vol. 258 (4) , 561-577
From structure to dynamics: Frequency tuning in the p53–Mdm2 network